approval · primary record
VASOPRESSIN
FDA · NDA · 2025-02-21
| Agency | FDA |
|---|---|
| Submission type | NDA |
| Action date | 2025-02-21 |
| Brand | VASOPRESSIN IN SODIUM CHLORIDE 0.9% |
| Sponsor | BAXTER HLTHCARE CORP |
| Route | INTRAVENOUS |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T02:35:20.935Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:VASOPRESSIN:2025-02-21
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.